Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease.
Eklöf J, Misiakou MA, Sivapalan P, Armbruster K, Browatzki A, Nielsen TL, Lapperre TS, Andreassen HF, Janner J, Ulrik CS, Gabrielaite M, Johansen HK, Jensen A, Nielsen TV, Hertz FB, Ghathian K, Calum H, Wilcke T, Seersholm N, Jensen JS, Marvig RL. Eklöf J, et al. Among authors: browatzki a. Clin Microbiol Infect. 2022 Jul;28(7):990-995. doi: 10.1016/j.cmi.2022.01.017. Epub 2022 Feb 3. Clin Microbiol Infect. 2022. PMID: 35124256 Free article. Clinical Trial.
A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol.
Sivapalan P, Moberg M, Eklöf J, Janner J, Vestbo J, Laub RR, Browatzki A, Armbruster K, Wilcke JT, Seersholm N, Weinreich UM, Titlestad IL, Andreassen HF, Ulrik CS, Bødtger U, Nielsen TL, Hansen EF, Jensen JUS. Sivapalan P, et al. Among authors: browatzki a. BMC Pulm Med. 2017 Aug 15;17(1):114. doi: 10.1186/s12890-017-0458-7. BMC Pulm Med. 2017. PMID: 28810909 Free PMC article. Clinical Trial.
Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients.
Eklöf J, Sørensen R, Ingebrigtsen TS, Sivapalan P, Achir I, Boel JB, Bangsborg J, Ostergaard C, Dessau RB, Jensen US, Browatzki A, Lapperre TS, Janner J, Weinreich UM, Armbruster K, Wilcke T, Seersholm N, Jensen JUS. Eklöf J, et al. Among authors: browatzki a. Clin Microbiol Infect. 2020 Feb;26(2):227-234. doi: 10.1016/j.cmi.2019.06.011. Epub 2019 Jun 22. Clin Microbiol Infect. 2020. PMID: 31238116 Free article.
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Sivapalan P, Ulrik CS, Bojesen RD, Lapperre TS, Eklöf JV, Håkansson KEJ, Browatzki A, Tidemansen C, Wilcke JT, Janner J, Gottlieb V, Meteran H, Porsbjerg C, Madsen BL, Moberg M, Pedersen L, Benfield TL, Lundgren JD, Knop FK, Biering-Sørensen T, Ghanizada M, Sonne TP, Bødtger UCS, Jensen SG, Rasmussen DB, Brøndum E, Tupper OD, Sørensen SW, Alstrup G, Laursen CB, Møller UW, Sverrild A, Jensen JS. Sivapalan P, et al. Among authors: browatzki a. Trials. 2020 Jun 10;21(1):513. doi: 10.1186/s13063-020-04409-9. Trials. 2020. PMID: 32522282 Free PMC article.
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan.
Sivapalan P, Ulrik CS, Lappere TS, Eklöf JV, Shaker SB, Bødtger UCS, Browatzki A, Meyer CN, Weinreich UM, Laursen CB, Biering-Sørensen T, Knop FK, Lundgren JD, Jensen JS. Sivapalan P, et al. Among authors: browatzki a. Trials. 2020 Oct 20;21(1):867. doi: 10.1186/s13063-020-04795-0. Trials. 2020. PMID: 33081817 Free PMC article. Clinical Trial.
Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.
Sivapalan P, Rutishauser J, Ulrik CS, Leuppi JD, Pedersen L, Mueller B, Eklöf J, Biering-Sørensen T, Gottlieb V, Armbruster K, Janner J, Moberg M, Lapperre TS, Nielsen TL, Browatzki A, Mathioudakis A, Vestbo J, Schüetz P, Jensen JU. Sivapalan P, et al. Among authors: browatzki a. Respir Res. 2021 May 21;22(1):155. doi: 10.1186/s12931-021-01745-5. Respir Res. 2021. PMID: 34020641 Free PMC article.
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial.
Sivapalan P, Ulrik CS, Lapperre TS, Bojesen RD, Eklöf J, Browatzki A, Wilcke JT, Gottlieb V, Håkansson KEJ, Tidemandsen C, Tupper O, Meteran H, Bergsøe C, Brøndum E, Bødtger U, Bech Rasmussen D, Graff Jensen S, Pedersen L, Jordan A, Priemé H, Søborg C, Steffensen IE, Høgsberg D, Klausen TW, Frydland MS, Lange P, Sverrild A, Ghanizada M, Knop FK, Biering-Sørensen T, Lundgren JD, Jensen JS; ProPAC-COVID writing group on behalf of the ProPAC-COVID Study Group. Sivapalan P, et al. Among authors: browatzki a. Eur Respir J. 2022 Jan 6;59(1):2100752. doi: 10.1183/13993003.00752-2021. Print 2022 Jan. Eur Respir J. 2022. PMID: 34083403 Free PMC article. Clinical Trial.
Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study.
Kamstrup P, Sivapalan P, Eklöf J, Hoyer N, Ulrik CS, Pedersen L, Lapperre TS, Harboe ZB, Bodtger U, Bojesen RD, Håkansson KEJ, Tidemandsen C, Armbruster K, Browatzki A, Meteran H, Meyer CN, Skaarup KG, Lassen MCH, Lundgren JD, Biering-Sørensen T, Jensen JU. Kamstrup P, et al. Among authors: browatzki a. Int J Infect Dis. 2021 Jul;108:370-376. doi: 10.1016/j.ijid.2021.05.076. Epub 2021 Jun 1. Int J Infect Dis. 2021. PMID: 34087484 Free PMC article.
19 results